Dearbhla Mescal revealed that she was preparing to become an 'empty nester' right around the time that she was diagnosed with ...
Carfilzomib prevented BCMA degradation, increased target density, and improved CAR T susceptibility by ~26%–28% in vitro, while enhancing xenograft antitumor activity without worsening T-cell ...
Current trial data suggest that many MCED tests demonstrate high specificity, often above 99% thereby reducing the likelihood of false positives ...
Hematological malignancies encompass a diverse range of diseases, such as leukemia, lymphoma, and multiple myeloma, among others. Within the multidisciplinary treatment approach, radiation therapy ...
RTE Late Late Show viewers have praised Dearbhla Mescal after she opened up about a “dark time” in her life. The Irish author joined Co Down host Patrick Kielty on the hit chat show ...
Gilead Sciences, Inc. shares have risen more than 43% over the past year. Click here to find out why GILD stock is a Sell.
The organization presented data aggregated from multiple clinical trials to explore ctDNA's potential as a surrogate endpoint predictive of treatment benefit in lung and other cancers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results